These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9159832)

  • 1. Erythropoietin treatment decreases cardiovascular morbidity and mortality in CAPD patients.
    Bajo MA; Selgas R; Castro MJ; Jiménez C; Fernández-Reyes MJ; Del Peso G; De Alvaro F; Sanchez-Sicilia AL
    Perit Dial Int; 1997; 17(2):129-35. PubMed ID: 9159832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anemia in peritoneal dialysis patients].
    Lausević M; Nesić V; Jovanović N; Stojimirović B
    Srp Arh Celok Lek; 2006; 134(3-4):133-7. PubMed ID: 16915754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hemoglobin concentration on peritoneal mass transfer and drain volumes in continuous ambulatory peritoneal dialysis.
    Hutchison AJ; Ofsthun NJ; Howarth D; Gokal R
    Perit Dial Int; 1992; 12(2):230-3. PubMed ID: 1586687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
    Navarro JF; Mora C; Macía M; García J
    Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal administration of recombinant human erythropoietin.
    Frenken LA; Struijk DG; Coppens PJ; Tiggeler RG; Krediet RT; Koene RA
    Perit Dial Int; 1992; 12(4):378-83. PubMed ID: 1420497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Law CB; Ting SM; Li P; Lai KN
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous recombinant human erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Pais MJ; Gaspar A; Santana A; Bruges M; Simões J
    Perit Dial Int; 1993; 13 Suppl 2():S541-3. PubMed ID: 8399660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor system components in relation to erythropoietin therapy and bone metabolism in dialyzed patients and kidney transplant recipients.
    Małyszko J; Wołczyński S; Zbroch E; Brzósko S; Małyszko J; Myśliwiec M
    Nephron; 2002 Mar; 90(3):282-9. PubMed ID: 11867949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R; Bloom E; Johnson R; Goldstein M
    Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of recombinant human erythropoietin treatment on cortisol responses to insulin-induced hypoglycemia in CAPD patients.
    Díez JJ; Iglesias P; Sastre J; Gómez-Pan A; Selgas R; Romero JR; Méndez J
    Adv Perit Dial; 1993; 9():336-41. PubMed ID: 8105958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of subcutaneous administration of recombinant human erythropoietin on plasma protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis.
    Lai KN; Yin JA; Li PK; Yuen PM; Lui SF
    Int J Artif Organs; 1992 May; 15(5):264-8. PubMed ID: 1601509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does parathyroid hormone affect erythropoietin therapy in dialysis patients?
    Al-Hilali N; Al-Humoud H; Ninan VT; Nampoory MR; Puliyclil MA; Johny KV
    Med Princ Pract; 2007; 16(1):63-7. PubMed ID: 17159367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis.
    Yalçinkaya F; Tümer N; Cakar N; Ozkaya N
    Pediatr Nephrol; 1997 Jun; 11(3):350-2. PubMed ID: 9203190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing capd.
    Tokgöz B; Utaş C; Doğukan A; Oymak O; Keleştimur F
    Ren Fail; 2002 May; 24(3):315-23. PubMed ID: 12166698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal recombinant human erythropoietin therapy: influence of the duration of continuous ambulatory peritoneal dialysis treatment and peritonitis.
    Huang TP; Lin CY
    Am J Nephrol; 1995; 15(4):312-7. PubMed ID: 7573189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of human recombinant erythropoietin on anaemia and dialysis efficiency in patients undergoing continuous ambulatory peritoneal dialysis.
    Steinhauer HB; Lubrich-Birkner I; Dreyling KW; Schollmeyer P
    Eur J Clin Invest; 1991 Feb; 21(1):47-52. PubMed ID: 1907554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin (rHuEPO) therapy has no effect on peritoneal transport in CAPD patients: a short-term study.
    Wong PN; Mak SK; Lo KY; Tong GM; Wong AK
    Adv Perit Dial; 1998; 14():11-3. PubMed ID: 10649682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous ambulatory peritoneal dialysis in end-stage renal disease due to multiple myeloma.
    Shetty A; Oreopoulos DG
    Perit Dial Int; 1995; 15(6):236-40. PubMed ID: 7578500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of once weekly erythropoietin therapy in children on continuous ambulatory peritoneal dialysis.
    Hisano S; Kaku Y; Ueda K; Onoyama K
    Acta Paediatr Jpn; 1991 Aug; 33(4):450-4. PubMed ID: 1792903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of proinflammatory cytokine gene and angiotensin-converting enzyme polymorphisms on erythropoietin requirements in patients on continuous ambulatory peritoneal dialysis.
    Sharples EJ; Varagunam M; Sinnott PJ; McCloskey DJ; Raftery MJ; Yaqoob MM
    Perit Dial Int; 2006; 26(1):64-8. PubMed ID: 16538877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.